Select Medical (NYSE:SEM) Posts Earnings Results, Misses Estimates By $0.11 EPS

Select Medical (NYSE:SEM) issued its quarterly earnings results on Thursday. The health services provider reported $0.18 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.11), Zacks reports. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. Select Medical updated its FY 2025 guidance to 1.090-1.190 EPS.

Select Medical Stock Down 0.8 %

NYSE SEM traded down $0.15 on Thursday, reaching $19.11. 975,271 shares of the stock traded hands, compared to its average volume of 792,814. Select Medical has a 12 month low of $18.02 and a 12 month high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a fifty day moving average price of $19.14 and a 200-day moving average price of $28.14. The company has a market cap of $2.47 billion, a price-to-earnings ratio of 8.93, a PEG ratio of 0.64 and a beta of 1.45.

Insider Transactions at Select Medical

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares in the company, valued at $463,980. This represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. UBS Group reduced their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, February 13th. Finally, Royal Bank of Canada upped their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $39.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.